Experience of low-dose aminophylline use to relieve minor adverse effects of dipyridamole in patients undergoing stress myocardial perfusion imaging.

Author: ChengCheng-Yi, HouCheng-Han, KuChih-Hung, LinLi-Fan, ShenDaniel H Y, TsengNeng-Chuan

Paper Details 
Original Abstract of the Article :
BACKGROUND: Intravenous administration of aminophylline is widely adopted to reverse dipyridamole-related adverse effects (AEs) during stress myocardial perfusion imaging (MPI). The study aimed to investigate the efficacy of lower-dose aminophylline to relieve minor AEs. METHODS: 2,250 consecutive ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s12350-014-9883-7

データ提供:米国国立医学図書館(NLM)

Low-Dose Aminophylline for Dipyridamole-Related Side Effects: A Practical Solution

[Stress myocardial perfusion imaging (MPI)] is a valuable diagnostic tool, but the use of [dipyridamole] can sometimes lead to adverse effects. This research explores the effectiveness of [low-dose aminophylline] in relieving minor adverse effects associated with dipyridamole during MPI.

A Safer Approach to MPI

The study reveals that [low-dose aminophylline (≦50mg, usually 25mg) is sufficient to alleviate mild dipyridamole-related side effects] in a large cohort of patients undergoing MPI. This finding suggests a [safer and more effective] approach to managing dipyridamole-related side effects during MPI.

Minimizing Side Effects for Better Patient Experience

This research emphasizes the importance of [minimizing side effects] during diagnostic procedures to enhance patient comfort and experience. It underscores the need for [continued research and optimization] of medication protocols to ensure the best possible outcomes for patients undergoing MPI.

Dr. Camel's Conclusion

This study provides a practical solution to a common challenge in MPI. Like a desert explorer finding a reliable source of water, low-dose aminophylline can effectively alleviate dipyridamole-related side effects, making the experience more comfortable for patients.

Date :
  1. Date Completed 2015-01-14
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24627347

DOI: Digital Object Identifier

10.1007/s12350-014-9883-7

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.